Off-Label-Use und Zulassung: ein Spagat bei der Behandlung von Minderjährigen

MeSH terms

• Adult
• Aftercare / standards
• Age Factors
• Cerebral Hemorrhage / drug therapy
• Cerebral Hemorrhage / genetics
• Child
• Clinical Trials as Topic / legislation & jurisprudence
• Clinical Trials as Topic / standards
• Drug Approval*
• Drugs, Investigational / therapeutic use*
• European Union
• Humans
• Infant, Newborn
• Infant, Premature
• Off-Label Use / legislation & jurisprudence*
• Pharmacogenomic Variants
• Pharmacovigilance*
• Pulmonary Disease, Chronic Obstructive / drug therapy
• Pulmonary Disease, Chronic Obstructive / genetics
• Rare Diseases / drug therapy
• Rare Diseases / genetics
• Risk Factors
• Time Factors